Brucellosis overview

Revision as of 15:18, 11 February 2016 by Danitza Lukac (talk | contribs)
Jump to navigation Jump to search

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis overview

CDC on Brucellosis overview

Brucellosis overview in the news

Blogs on Brucellosis overview

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza Lukac

Overview

Brucellosis is a zoonosis (infectious disease transmitted from animals to humans) caused by bacteria of the genus Brucella. Brucella is usually transmitted via the digestive route to the human host. Following transmission, white blood cells phagocyte the pathogen and transports it via the hematologic or lymphatic route to different organs, specially to those of the reticuloendothelial system.[1][2] Brucellosis must be differentiated from typhoid fever, malaria, tuberculosis, lymphoma, dengue, leptospirosis and rheumatic diseases.[3] Brucellosis is not very common in the United States, but brucellosis can be very common within countries that do not have good standardized and effective public health and domestic animal health programs. Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.[4] Common risk factors in the development of brucellosis are consuming unpasteurized dairy products, unsafe hunting practices and occupational risks such as slaughther house workers, meat-packing employees, veterinarian and laboratory workers.[4] If left untreated, patients with brucellosis may progress to develop focal infections, relapses or chronic brucellosis.[5] Common complications of brucellosis include granulomatous hepatitis, arthritis, sacroiliitis, meningitis, orchitis, epididymitis uveitis, and endocarditis. The prognosis of brucellosis is good with adequate treatment. Relapse may occur, and symptoms may continue for years.[5][6][7] Symptoms of brucellosis include undulant fever, night sweats (with characteristic smell, likened to wet hay), and joint pain.[7] Patients with brucellosis are usually well-appearing.[2] Common physical examination findings include hepatomegaly, splenomegaly, and lymphadenopathy.[8] The mainstay of therapy for brucellosis is antimicrobial therapy. The preferred regimen for uncomplicated brucellosis is a combination of Doxycycline and Streptomycin. Rifampin is the drug of choice for brucellosis in pregnancy. For children less than 8 years of age, the preferred regimen is either Gentamycin or a combination of Trimethoprim-sulfamethoxazole and Streptomycin.[7][9] The optimal way to prevent brucellosis is by not consuming unpasteurized dairy or undercooked meat, and having safe occupational practices. There are no available vaccines for humans against brucellosis.[7][10]

Historial Perspective

In 1887, David Bruce, a Scottish pathologist and microbiologist, was the first to discover the association between Brucella and the development of brucellosis.[7]

Pathophysiology

Brucella is usually transmitted via the digestive route to the human host. Following transmission, white blood cells phagocyte the pathogen and transport it via the hematologic or lymphatic route to different organs, specially those of the reticuloendothelial system.[1][2]

Causes

Human brucellosis is caused by four Brucellae species: B. abortus, B. canis, B. melitensis, and B. suis.[11]

Differentiating Brucellosis from other Diseases

Brucellosis must be differentiated from typhoid fever, malaria, tuberculosis, lymphoma, dengue, leptospirosis and rheumatic diseases.[3]

Epidemiology and Demographics

Brucellosis is not very common in the United States, but brucellosis can be very common within countries that do not have good standardized and effective public health and domestic animal health programs. Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.[4]

Risk Factors

Common risk factors in the development of brucellosis are consuming unpasteurized dairy products, unsafe hunting practices and occupational risks such as slaughther house workers, meat-packing employees, veterinarian, and laboratory workers.[4]

Screening

There are no guidelines for brucellosis screening. Some endemic areas screen family members of patients with brucellosis. [12] [13]

Natural history, Complications and Prognosis

If left untreated, patients with brucellosis may progress to develop focal infections, relapses or chronic brucellosis.[5] Common complications of brucellosis include granulomatous hepatitis, arthritis, sacroiliitis, meningitis, orchitis, epididymitis uveitis, and endocarditis. The prognosis of brucellosis is good with adequate treatment. Relapse may occur, and symptoms may continue for years.[5][6][7]

Diagnosis

Criteria

The diagnosis of brucellosis is based on clinical and laboratory criteria.[14]

History and Symptoms

Symptoms of brucellosis include undulant fever, night sweats (with characteristic smell, likened to wet hay), and joint pain.[7]

Physical Examination

Patients with brucellosis are usually well-appearing.[2] Common physical examination findings include hepatomegaly, splenomegaly, and lymphadenopathy.[8]

Laboratory Findings

A positive culture or presence of Brucella antibody in serological tests are diagnostic of brucellosis.[14]

Other Diagnostic Studies

Spine x-ray, CT o MRI may be helpful in the diagnosis of focal brucellosis infection. Findings of Pedro Pons sign can be suggestive of brucellic spondylitis.[15]

Treatment

Medical Therapy

The mainstay of therapy for brucellosis is antimicrobial therapy. The preferred regimen for uncomplicated brucellosis is a combination of Doxycycline and Streptomycin. Rifampin is the drug of choice for brucellosis in pregnancy. For children less than 8 years of age, the preferred regimen is either Gentamycin or a combination of Trimethoprim-sulfamethoxazole and Streptomycin.[7][9]

Prevention

Effective measures for the primary prevention of brucellosis include not consuming unpasteurized dairy or undercooked meat, and having safe occupational practices. There are no available vaccines for humans against brucellosis.[10][7]

References

  1. 1.0 1.1 Corbel MJ (1997). "Brucellosis: an overview". Emerg Infect Dis. 3 (2): 213–21. doi:10.3201/eid0302.970219. PMC 2627605. PMID 9204307.
  2. 2.0 2.1 2.2 2.3 Brucelosis. Wikipedia. https://es.wikipedia.org/wiki/Brucelosis. Accessed on February 2, 2016
  3. 3.0 3.1 Enfermedades infecciosas: Brucelosis -Diagnóstico de Brucelosis,Guia para el Equipo de Salud. Ministerio de Salud-Argentina. http://www.msal.gob.ar/images/stories/bes/graficos/0000000304cnt-guia-medica-brucelosis.pdf. Accessed on February 2, 2016
  4. 4.0 4.1 4.2 4.3 Brucellosis. CDC. http://www.cdc.gov/brucellosis/exposure/index.html.html. Accessed on February 3, 2016
  5. 5.0 5.1 5.2 5.3 Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016
  6. 6.0 6.1 FAO/WHO/OIE Brucellosis in humans and animals. WHO (2006). http://www.who.int/csr/resources/publications/Brucellosis.pdf Accessed on February 3, 2016
  7. 7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 Brucellosis. Wikipedia. https://en.wikipedia.org/wiki/Brucellosis. Accessed on February 1, 2016
  8. 8.0 8.1 Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005). "Brucellosis". N Engl J Med. 352 (22): 2325–36. doi:10.1056/NEJMra050570. PMID 15930423.
  9. 9.0 9.1 Brucellosis. CDC. http://www.cdc.gov/brucellosis/treatment/index.html. Accessed on February 5, 2016
  10. 10.0 10.1 Brucellosis. CDC. http://www.cdc.gov/brucellosis/prevention/index.html. Accessed on February 5, 2016
  11. Brucella. Wikipedia. https://en.wikipedia.org/wiki/Brucella#Characteristics. Accessed on February 2, 2016
  12. Sanodze L, Bautista CT, Garuchava N, Chubinidze S, Tsertsvadze E, Broladze M; et al. (2015). "Expansion of brucellosis detection in the country of Georgia by screening household members of cases and neighboring community members". BMC Public Health. 15: 459. doi:10.1186/s12889-015-1761-y. PMC 4432945. PMID 25934639.
  13. Tabak F, Hakko E, Mete B, Ozaras R, Mert A, Ozturk R (2008). "Is family screening necessary in brucellosis?". Infection. 36 (6): 575–7. doi:10.1007/s15010-008-7022-6. PMID 19011744.
  14. 14.0 14.1 Brucellosis 2010 Case Definition. CDC. http://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/. Accessed on February 2, 2016
  15. Pourbagher A, Pourbagher MA, Savas L, Turunc T, Demiroglu YZ, Erol I; et al. (2006). "Epidemiologic, clinical, and imaging findings in brucellosis patients with osteoarticular involvement". AJR Am J Roentgenol. 187 (4): 873–80. doi:10.2214/AJR.05.1088. PMID 16985128.